Almac's Clinical Technologies business unit has formed an alliance with Greenphire to offer joint services relating to patient payment administration for clinical trials.
This service is intended to improve current methods of manual patient payment management while alleviating administrative burden on personnel in biopharmaceutical companies and contract research organisations (CROs), allowing them to focus on more study-specific responsibilities.
Greenphire has worked with Almac to incorporate its Clincard system, a patient payment management suite of technologies, with Almac's interactive voice and web response (IXRS) system, an integrated phone and web platform.
This offering provides patients with direct and timely compensation via a branded debit card.
After patients complete required study-related tasks and responsibilities (such as attending site visits), their debit card is automatically and immediately credited with the appropriate stipend or reimbursement amount.
The Almac-Greenphire alliance provides several benefits to biopharmaceutical companies.
The integrated platform improves operational efficiency, decreases sponsor, site and CRO administrative burden, reduces payment administration costs and timelines and increases site and patient satisfaction.
